Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
0.3600
0.00 (0.00%)
Mar 28, 2025, 4:10 PM EST
TSXV:EBM Revenue
In the fiscal year ending October 31, 2024, Eastwood Bio-Medical Canada had annual revenue of 702.08K CAD, down -19.11%. Eastwood Bio-Medical Canada had revenue of 177.61K in the quarter ending October 31, 2024, with 37.60% growth.
Revenue
702.08K
Revenue Growth
-19.11%
P/S Ratio
35.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 702.08K | -165.86K | -19.11% |
Oct 31, 2023 | 867.94K | -431.83K | -33.22% |
Oct 31, 2022 | 1.30M | 318.71K | 32.49% |
Oct 31, 2021 | 981.05K | 262.72K | 36.57% |
Oct 31, 2020 | 718.34K | -574.56K | -44.44% |
Oct 31, 2019 | Pro | Pro | Pro |
Oct 31, 2018 | Pro | Pro | Pro |
Oct 31, 2017 | Pro | Pro | Pro |
Oct 31, 2016 | Pro | Pro | Pro |
Oct 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Loblaw Companies | 61.01B |
Dollarama | 6.17B |
George Weston | 61.61B |
Metro | 21.36B |
Empire Company | 31.12B |
Saputo | 18.85B |
Premium Brands Holdings | 6.47B |
Maple Leaf Foods | 4.90B |